EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics

Hiroaki Murayama, Akira Endo, Shouto Yonekura

Epidemics · 2023

DOI: 10.1016/j.epidem.2023.100726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epidemics, 2023. Verfasst von Hiroaki Murayama und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, International University of Health and Welfare, Narita, Japan; Graduate School of Social Sciences, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Vaccine Efficacy, Epidemics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monitoring time-varying vaccine effectiveness (e.g., due to waning of immunity and the emergence of novel variants) provides crucial information for outbreak control. Existing studies of time-varying vaccine effectiveness have used individual-level data, most importantly dates of vaccination and variant classification, which are often not available in a timely manner or from a wide range of population groups. We present a novel Bayesian framework for estimating the waning of variant-specific vaccine effectiveness in the presence of multi-variant circulation from population-level surveillance data. Applications to simulated outbreaks and the COVID-19 epidemic in Japan are also presented. Our results show that variant-specific waning vaccine effectiveness estimated from population-level surveillance data could approximately reproduce the estimates from previous test-negative design studies, allowing for rapid, if crude, assessment of the epidemic situation before fine-scale studies are made available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine EfficacyEpidemicsBayes TheoremVaccinationDisease Outbreaks

Stichwörter der Autor:innen

Bayesian inferenceCOVID-19Multi-pathogenPopulation-level surveillance dataWaning vaccine effectiveness

Autor:innen und Institutionen

  • School of Medicine, International University of Health and Welfare, Narita, Japan; Graduate School of Social Sciences, Chiba University, Chiba, Japan.
  • Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medi…
  • Graduate School of Social Sciences, Chiba University, Chiba, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Precursory Research for Embryonic Science and Technology
  • Japan Society for the Promotion of Science London
  • Japan Agency for Medical Research and Development

Zitieren

APA

Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics. https://doi.org/10.1016/j.epidem.2023.100726

Vancouver

Murayama H, Endo A, Yonekura S. Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics. 2023. doi:10.1016/j.epidem.2023.100726

BibTeX
@article{Murayama2023,
  author = {Murayama, Hiroaki and Endo, Akira and Yonekura, Shouto},
  title = {Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics},
  journal = {Epidemics},
  year = {2023},
  doi = {10.1016/j.epidem.2023.100726}
}
Kostenlos starten →